Aerie Pharmaceuticals Logo
Aerie Pharma Homepage Hero Image 1

A VISIONaerie® approach

We discover, develop, and commercialize first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases.

Learn More

Join us in creating the future of eye care!

Learn More

Our Products

We currently market two innovative prescription eye drops for lowering intraocular pressure (IOP) in glaucoma.

Learn More

Our Research

We are making significant progress in developing new treatments for dry eye and retinal diseases.

Learn More

STOCK Quote

NASDAQ: AERI

$15.06USD


Aug 3, 2:22 PM ET

Latest News

Social Media

Aerie Pharma Ophthalmic Products

DISCOVaerie™ Live!

Visit our virtual destination for the eye care community to get informed and connected.

MORE
Aerie Pharma Careers

CAREERS AT AERIE

We are looking for VISIONaerieS® who share our passion for innovation to protect sight.

MORE
Aerie Pharma ESG Commitment

OUR ESG COMMITMENT

Aerie is dedicated to environmental stewardship, social responsibility, and good corporate governance.

MORE
TOP